- Valeant files overdue financial report, ending debt default Updated: Apr-29-16 4:36 pm
Valeant Pharmaceuticals resolved its default on some of its $30 billion in debt by finally filing its long-overdue U.S. financial report for 2015 on Friday. The badly tarnished Canadian drugmaker also announced a slate of mostly new nominees for elections to its board in June.
- Lawmakers blast Valeant for price-gouging tactics Updated: Apr-27-16 7:42 pm
WASHINGTON - Lawmakers accused Valeant Pharmaceuticals of gouging patients to reward Wall Street investors during a hearing Wednesday scrutinizing the embattled drugmaker's pricing tactics.
- Canadian Pacific says railroads will need mergers in future Updated: Apr-20-16 2:49 pm
OMAHA, Nebraska - The CEO of Canadian Pacific still thinks railroad mergers are needed if the industry is to handle more freight, even after the company's bid for Norfolk Southern crumbled under stiff resistance.
- Valeant CEO agrees to be deposed in Senate drug price probe Updated: Apr-13-16 12:55 pm
The chief executive of embattled Valeant Pharmaceuticals, J. Michael Pearson, has agreed to be deposed by a Senate committee investigating the causes of soaring prescription medicine prices.